Literature DB >> 21459175

Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance.

Maria Giufrè1, Rita Cardines, Maria Grazia Caporali, Marisa Accogli, Fortunato D'Ancona, Marina Cerquetti.   

Abstract

The introduction of Haemophilus influenzae type b (Hib) conjugate vaccines has greatly reduced the incidence of invasive Hib disease. However, concern exists about the possible emergence of "strain replacement". We report the epidemiology and characterization of isolates from invasive H. influenzae disease in Italy through 2007-2009, 10 years after Hib vaccination was introduced. Invasive H. influenzae disease cases were detected through the National Surveillance of Invasive Bacterial Disease. Seventy-eight H. influenzae strains were serotyped and tested for antimicrobial susceptibility. Genetic basis of resistance to β-lactams was investigated. The annual incidence of invasive H. influenzae infection was 0.06/100,000 in 2007, 0.08/100,000 in 2008 and 0.09/100,000 in 2009 in all age groups. A slight increase in disease incidence has been observed in adults ≥65 years since 2007. Nonencapsulated (ncHi) predominated among H. influenzae isolates from all age groups: 61.5%, 76.0%, and 75.0% for <5, 5-64 and ≥65 years, respectively. Although ncHi mainly caused bacteremia, meningitis due to ncHi increased in comparison with previous data (38.6% in 2007-2009 vs. 26.2% 1997-2002). Prevalence of encapsulated non-Hib strains grew significantly (4.1% in 1997-2002 vs.16.7% in 2007-2009; p<0.001), although they remained rare. Resistance to ampicillin mediated by β-lactamase declined, but that due to altered penicillin-binding protein 3 increased. In conclusion, routine use of Hib vaccines produced both a drastic decrease in the number of invasive H. influenzae cases and epidemiological changes in disease. Overall, pediatric H. influenzae disease has become less common whereas there has been a slight increase of disease in the elderly. A marked change in the predominant serotype from Hib to ncHi has occurred. Changes in the H. influenzae population moderately affected antibiotic resistance trends.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459175     DOI: 10.1016/j.vaccine.2011.03.059

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

Review 1.  Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.

Authors:  Timothy F Murphy
Journal:  Clin Vaccine Immunol       Date:  2015-03-18

2.  The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia.

Authors:  Eran Lavi; Oded Breuer
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

3.  Characteristics of Haemophilus influenzae invasive isolates from Portugal following routine childhood vaccination against H. influenzae serotype b (2002-2010).

Authors:  M P Bajanca-Lavado; A S Simões; C R Betencourt; R Sá-Leão
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-24       Impact factor: 3.267

4.  Why we need a vaccine for non-typeable Haemophilus influenzae.

Authors:  Marina Cerquetti; Maria Giufrè
Journal:  Hum Vaccin Immunother       Date:  2016-05-12       Impact factor: 3.452

5.  Antimicrobial resistance among Haemophilus influenzae isolates responsible for lower respiratory tract infections in Poland, 2005-2019.

Authors:  Marlena Kiedrowska; Weronika Jasmina Foryś; Agnieszka Gołębiewska; Izabela Waśko; Patrycja Ronkiewicz; Alicja Kuch; Izabela Wróbel-Pawelczyk; Michał Wroczyński; Waleria Hryniewicz; Anna Skoczyńska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-18       Impact factor: 3.267

6.  Identification of Haemophilus influenzae clones associated with invasive disease a decade after introduction of H. influenzae serotype b vaccination in Italy.

Authors:  Maria Giufrè; Rita Cardines; Marisa Accogli; Manuela Pardini; Marina Cerquetti
Journal:  Clin Vaccine Immunol       Date:  2013-06-12

7.  Characterisation of invasive clinical Haemophilus influenzae isolates in Queensland, Australia using whole-genome sequencing.

Authors:  M Staples; R M A Graham; A V Jennison
Journal:  Epidemiol Infect       Date:  2017-03-06       Impact factor: 4.434

8.  Invasive Haemophilus influenzae serotype e and f disease, England and Wales.

Authors:  Shamez N Ladhani; Sarah Collins; Anna Vickers; David J Litt; Carina Crawford; Mary E Ramsay; Mary P E Slack
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

9.  Evaluation of Haemophilus influenzae type b carrier status among children 10 years after the introduction of Hib vaccine in Brazil.

Authors:  Rosemeire Cobo Zanella; Maria Cristina de Cunto Brandileone; Ana Lúcia Andrade; Cinthya Terumi Ogassavara; Cleiton Eduardo Fiório; Angela Pires Brandão; Samanta Cristine Grassi Almeida; Ana Paula Silva Lemos; Maria Cecília Gorla; Telma Regina Carvalhanas; Helena Sato; Bernadete Liphaus; Maria Lígia Nerger; Monica Conde; Ana Freitas Ribeiro
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-09       Impact factor: 2.743

Review 10.  Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use.

Authors:  M P E Slack; A W Cripps; K Grimwood; G A Mackenzie; M Ulanova
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.